Participants of the CU Boulder study
“We have received a lot of e-mails that are trying to get them started. It’s great to see them because they are very interested in helping. Vaccines.” That is, “We understand what this research is and we hope Participate in it for a long time and become part of the solution,” DeSouza added.
Chase Willie, a senior at the Boulder campus, was never completely sure how such a project would work.
Willie said: “I told my father that I always wanted to know who was part of these studies because you heard about them in the news.” “I always wondered,’Who are they talking to?'”
Therefore, when Willie’s girlfriend forwarded him an email about COVID U prevention, he decided to submit an application. Then, the media design major participated in an information conference about the research, where he learned that participation might mean waiting until later this year before being stabbed. However, by then, he felt that he had become part of the important thing, so he decided to continue to participate in the trial.
He said: “This research is answering the big questions that the entire country is using these vaccines now.” “Once you get the vaccine, can you still spread the virus to other people? I think this is also a question I have always wanted to know. And I’ve always wanted to find out. Even if I didn’t get the vaccine right away, it’s really cool to be part of the research to answer this question.
It turns out that Willie was assigned to an earlier group and received his first shot of “Moderna” last week.
Dr. Amesh Adalja, a senior scholar at the Johns Hopkins University Health and Safety Center in Baltimore, said this research will benefit everyone.
“The main reason why it is important is because it does affect the way public health guidelines are issued. We are already [transmission] Information from the US Centers for Disease Control and Prevention, as well as data from health care workers, and real data from areas with high immunization rates such as Israel,” Adalja said.